Search

Your search keyword '"Simard, Jacques"' showing total 1,982 results

Search Constraints

Start Over You searched for: Author "Simard, Jacques" Remove constraint Author: "Simard, Jacques"
1,982 results on '"Simard, Jacques"'

Search Results

202. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

203. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

204. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

205. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

206. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

208. A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study

209. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

211. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

212. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers

213. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

214. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

215. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

216. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

217. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants

218. RAD51 135G C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

220. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

221. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

222. Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

223. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

224. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

225. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (vol 22, 8, 2020)

226. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

227. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

228. Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations

229. Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians

230. Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians

231. Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing heterozygous familial hypercholesterolemia among French Canadians

232. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

233. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants:Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

234. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers:Results from The BRCA1 and BRCA2 Cohort Consortium

235. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk:an international prospective cohort of BRCA1 and BRCA2 mutation carriers

236. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

237. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from The BRCA1 and BRCA2 Cohort Consortium

240. Using the Impact of Event Scale to evaluate distress in the context of genetic testing for breast cancer susceptibility

241. Women’s Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada

242. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the International Consortium for Prostate Cancer Genetics

245. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

246. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

247. The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

248. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

249. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

250. Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History

Catalog

Books, media, physical & digital resources